Treatment of psychiatric comorbidities in a patient with Becker muscular dystrophy

Psychosomatics

Volumn 48, Issue 2, 2007, Pages 167-169

  Chaichana, Kaisorn L ^a   Buffington, Angela L H ^a   Brandes, Mina ^a   Edwin, David ^a   Lee, Hochang B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; RISPERIDONE; SERTRALINE; TRAZODONE;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; COMORBIDITY; DEPRESSION; DISABILITY; DISEASE SEVERITY; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; PHYSIOTHERAPY; PSYCHOPHARMACOTHERAPY;

EID: 33847607065     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.2.167     Document Type: Letter

References (9)

1. Emery AE: Muscular dystrophy into the new millennium. Neuromuscul Disord 2002; 12:343-349
2. North KN, Miller G, Iannaccone ST, et al: Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophy. Neurology 1996; 46:461-464
3. Karagan NJ, Sorensen JP: Intellectual functioning in non-Duchenne muscular dystrophy. Neurology 1981; 31:452-458
4. Melo M, Lauriano V, Gentil V, et al: Becker and limb-girdle muscular dystrophies: a psychiatric and intellectual-level comparative study. Am J Med Genet 1995; 60:33-38
5. Florencia G, Veronica F, Viviana D, et al: Dystrophin deletion and cognitive impairment in Duchenne/Becker muscular dystrophy. Neurol Res 2004; 26:83-87
6. Bardona A, Sironi M, Felisari G, et al: Absence of brain Dp-140 isoform and cognitive impairment in Becker muscular dystrophy. Lancet 1999; 353:897-898
7. Zatz M, Vallada H, Melo MS, et al: Co-segregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for schizophrenia at Xp-21 or an effect of the dystrophin gene in the brain? J Med Genet 1993; 30:131-134
8. Lindor NM, Sobell JL, Heston LL, et al: Screening the dystrophin gene suggests a high rate of polymorphisms in general but no exonic deletions in schizophrenics. Am J Genet 1994; 54:1-4
9. Kirwin JL, Goren JL: Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy 2005; 25:396-410